Other
Post-Craniotomy
0
Pipeline Programs↗
2
Active Trials↗
0
Companies Involved↗
Post-craniotomy is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Unknown status5 · 45%
Completed3 · 27%
Active, not recruiting1 · 9%
Withdrawn1 · 9%
Recruiting1 · 9%
Clinical Trials
Trial Activity
11 trials
Pre-emptive Scalp Infiltration with Triamcinolone Acetonide Plus Ropivacaine for Post-Craniotomy Pain in Children
Recruiting·—·Phase 4·NCT06779396·128 enrolled
Pre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-Craniotomy Pain in Children
Completed·—·Phase 4·NCT04051723·80 enrolled
Triamcinolone Acetonide as an Adjuvant to Pre-emptive Scalp Infiltration for Relief of Post-craniotomy Pain in Adults
Completed·—·Phase 4·NCT06069804·110 enrolled
Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain
Unknown status·—·Phase 3·NCT04169854·180 enrolled
Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain
Unknown status·—·Phase 4·NCT04034836·132 enrolled
Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-craniotomy Pain
Unknown status·—·Phase 4·NCT04488315·130 enrolled
Effects of Pre-emptive Scalp Infiltration With Ketorolac and Ropivacaine for Post-craniotomy Pain
Unknown status·—·Phase 4·NCT04141319·100 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)